Endoscopy & Visualization in California

Stellartech Research Corporation is an ISO 13485:2016-registered contract manufacturer and product development partner specializing in sophisticated medical devices utilizing radiofrequency, ultrasound, and other energy-delivery sources. The company designs and manufactures complex medical systems that typically combine disposable patient-contact devices with microprocessor-controlled instruments featuring advanced electronics for sensor feedback and controlled therapeutic energy delivery. Core competencies include catheter-based systems (including balloon electrode catheters), surgical probes, diagnostic instruments, and minimally invasive therapy devices. Stellartech operates a 68,000 sq. ft. facility capable of manufacturing Class II and Class III devices under FDA QSR compliance and ISO 13485:2016 quality management systems. Beyond contract manufacturing, the company provides full-spectrum product development services—from concept and proof-of-principle through clinical evaluation, regulatory approval, and market introduction. Stellartech partners with device companies of all sizes, medical entrepreneurs, physicians, and investment groups, offering incubation services for new medical device enterprises using its manufacturing infrastructure and regulatory expertise. The company brings integrated capabilities in RF and ultrasound energy systems, complex electronics design, catheter technology, and regulatory pathway management, positioning it as a strategic partner for medical device innovators seeking to navigate the product development lifecycle.

Palliare is a medtech company specializing in insufflation systems for minimally invasive surgical and endoscopic procedures. The company designs and manufactures the EVA15 Insufflator, a modernized insufflation device that delivers hands-free control and constant pressure maintenance in the surgical working field. The EVA15 is indicated for use in laparoscopic surgery, colorectal procedures, endolumenal interventions, and robotic-assisted surgery. The system provides automated insufflation management, reducing manual intervention during procedures and improving operational efficiency in the OR and endoscopy suite. Palliare positions itself as a technology leader focused on advancing insufflation capabilities to support the growing adoption of minimally invasive techniques across surgical specialties. The company has received recognition in the medtech industry, winning the Emerging Medtech Company of the Year award at the 2025 Irish Medtech Awards, indicating strong market validation and innovation credentials.

Grifols is a leading global biopharmaceutical and healthcare company founded in 1909, headquartered in Barcelona with significant US operations. The company operates across four primary business divisions: Biopharma (plasma-derived medicines and biopharmaceuticals for immunology, hepatology, intensive care, pulmonology, hematology, neurology, and infectious diseases), Diagnostic (blood screening and transfusion medicine diagnostics), Bio Supplies (plasma collection and processing supplies), and Healthcare Solutions for Hospitals (hospital equipment and consumables). Grifols manufactures and distributes innovative plasma-derived therapeutic products, clinical laboratory equipment and reagents, diagnostic assays, and healthcare infrastructure solutions for hospital and transfusion medicine settings. The company operates a global plasma donation center network and engages in research and development across multiple therapeutic areas, including immunological disorders, rare diseases, and infectious disease screening. Grifols maintains regulatory compliance with FDA approvals (evidenced by recent malaria blood screening assay approval), ISO standards, and international quality certifications. The company serves healthcare systems, blood banks, hospitals, clinical laboratories, and patients globally, with established operations and partnerships across the Americas, Europe, and Asia-Pacific regions.

Fovia, Inc. is a leading provider of cloud-based, vendor-neutral AI visualization and advanced medical imaging software solutions. The company develops F.A.S.T.® aiCockpit® and F.A.S.T.® AI SDK—flagship products that enable radiologists and clinicians to efficiently access and interact with AI results directly within their existing PACS, reporting software, and hospital systems without launching external viewers. Fovia's comprehensive product suite includes F.A.S.T.® AI Annotation, F.A.S.T.® AI Validation, F.A.S.T.® AI Workflows, F.A.S.T.® Interactive AI, and F.A.S.T.® Interactive Segmentation, providing OEMs and enterprises with tools for annotation, validation, modification, segmentation, and AI result management in 2D and 3D. The platform consolidates multi-vendor AI algorithm results into a single unified interface, streamlining radiology workflows and reducing integration complexity. With over 20 years of radiology integration experience, Fovia offers flexible deployment options (floating web application, embedded browser, widget mode, or SDK implementation) and supports seamless integration across diverse platforms and operating systems for both clinical and research applications.

Intuitive Surgical, Inc. is a global leader in robotic-assisted surgical systems and digital health solutions. The company manufactures the da Vinci family of robotic surgery platforms, which enable minimally invasive surgical procedures across multiple specialties including general surgery, urology, gynecology, cardiothoracic, and orthopedics. Core product lines include the da Vinci 5 (advanced integrated robotic platform with surgeon console and patient cart), the da Vinci SP (single-port robotic system for new surgical approaches), and the Ion robotic bronchoscopy system for lung cancer diagnosis and biopsy. Intuitive also manufactures da Vinci instruments and accessories designed for precision and ergonomic control. Beyond hardware, the company provides digital solutions including My Intuitive (data analytics and insights platform for surgical teams) and SimNow (surgeon training and simulation software). The company operates a global infrastructure with expanded direct operations in Europe and provides 24/7 service and support. Intuitive's systems are used in hospitals worldwide for minimally invasive surgery, and the company has established itself as the market leader in robotic-assisted surgical technology since its founding in 1995. The platform emphasizes surgeon autonomy, precision, and patient outcomes through advanced visualization and control systems.

United Imaging Healthcare develops and manufactures advanced medical imaging equipment with a mission to provide Equal Healthcare for All. The company produces a comprehensive multi-modality portfolio including CT, MRI, PET/CT, and digital X-ray systems. Key product lines include the uCT® ATLAS CT scanner (up to 640 slices), uMR® 680 1.5T MRI system with uAiFI AI capabilities, uMI® Panorama digital high-resolution PET/CT, and uDR® 380i Pro digital mobile X-ray systems. The company also manufactures the uDR® Aurora CX system and operates translational imaging, interventional X-ray, and remote scanning capabilities. United Imaging serves hospital systems, diagnostic imaging centers, precision medicine facilities, and rural healthcare providers across the United States. The company has demonstrated FDA clearance for multiple products and maintains active research partnerships with academic medical centers including UCSF and UC Davis, focusing on applications in oncology, infectious disease diagnosis, and precision healthcare. Products emphasize accessibility, clinical intelligence, and high-resolution imaging capabilities. The organization participates actively in major medical imaging conferences including RSNA, AHRA, SNMMI, and ISMRM.

Universal Diagnostic Solutions (UDS) is an FDA-registered medical device distributor and reseller specializing in new, pre-owned, refurbished, and demo ultrasound imaging systems and complementary diagnostic medical equipment. With over 15 years of experience, UDS represents all major ultrasound manufacturers including GE, Philips, Mindray, Sonosite, Samsung, and Terason. The company provides a full-service model encompassing sales consultation, equipment customization, installation, operator training, and ongoing technical support. Product portfolio includes portable and console-based ultrasound systems, C-arm fluoroscopy X-ray equipment, vital signs monitors (NIBP, SpO2, temperature), patient examination tables (partnered with Oakworks for abdominal, musculoskeletal, vascular, and biopsy applications), and automated external defibrillators (AEDs). UDS serves diverse markets including private practices, academic medical centers, veterinary sonography, osteopathic schools, and rehabilitation clinics. The company operates a warehouse facility in Vista, California, and offers nationwide distribution with localized support through manufacturer partnerships (Mindray and Edan maintain US service locations). UDS is compliant with California State Board of Pharmacy regulations and authorized to sell Class II medical devices. The company emphasizes personalized customer engagement, rapid service turnaround, competitive pricing strategies (advertising 40% discounts on console systems), and extensive product knowledge to assist buyers in navigating the complex diagnostic imaging marketplace.

Composite Manufacturing, Inc. (CMI) is an FDA-registered manufacturer and biomedical engineering company specializing in advanced carbon fiber and composite medical device design and production. For over 40 years, CMI has engineered custom composite solutions for neurological surgery, interventional neuroradiology, orthopedic procedures, urological interventions, and general surgical practices. The company manufactures radiolucent patient positioning systems, surgical tables, and imaging-compatible equipment featuring carbon fiber composites that are up to 5x stronger than aluminum at a fraction of the weight. CMI provides end-to-end capabilities including in-house design, tooling, prototyping, and manufacturing with vertical integration ensuring superior quality control, cost efficiency, and rapid market response. Their proprietary technologies enable complex geometries and high-performance solutions for demanding medical, surgical, and imaging applications.

Invenio Imaging, Inc. develops and commercializes the NIO Laser Imaging System, a stimulated Raman histology (SRH) platform that enables rapid, label-free tissue imaging for intraoperative pathology assessment. The NIO system delivers high-quality histological images in under 3 minutes without requiring tissue staining or sectioning, allowing on-site evaluation by surgical and pathology staff. The platform features the NIO Slide sample preparation module and integrates natively with existing hospital IT infrastructure via DICOM interfaces for digital image sharing and archiving. Invenio Imaging also offers NIO Glioma Reveal, a deep learning–based image analysis algorithm for identifying cancer infiltration in glioma surgery; this product has received CE Mark approval in the European Union and is available for research use only in the United States. The company serves multiple surgical specialties including neurosurgery, interventional pulmonology, urology, ENT, breast oncology, GI endoscopy, organ transplantation, and nephrology. The technology preserves tissue viability for downstream molecular and genetic analysis, enabling pathologists to conduct additional studies on the same specimen. The NIO platform has exceeded 2,000 installed systems globally and is supported by clinical evidence from leading academic medical centers including NYU Langone Health and University of Freiburg.

NeoLight, LLC manufactures specialized medical devices for neonatal intensive care, including brain monitoring, retinal imaging, phototherapy, and developmental support systems. The company's product portfolio addresses critical clinical needs in NICU environments: the nëo™ CFM with aEEG provides cerebral function monitoring to support decision-making in neurological assessment; the ICON™ retinal imaging system with patented Direct Illumination™ technology enables screening for retinopathy of prematurity and other ocular conditions; the Skylife™ Neonatal Phototherapy System delivers spectral power-optimized treatment for neonatal jaundice; and the P.A.L. (Pacifier-Activated Latch) device encourages non-nutritive sucking to promote oral feeding development in preterm and critically ill infants. NeoLight's devices are designed for use in tertiary and secondary neonatal care settings, emphasizing evidence-based clinical outcomes and user-centered design. The company positions itself as a neonatal innovation leader integrating advanced monitoring, diagnostic imaging, and therapeutic technologies to improve developmental outcomes and reduce NICU length of stay.